Annual Interest Expense
N/A
31 December 2023
Summary:
Marker Therapeutics annual interest expense is not available.MRKR Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
N/A
30 September 2024
Summary:
Marker Therapeutics quarterly interest expense is not available.MRKR Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
N/A
30 September 2024
Summary:
Marker Therapeutics TTM interest expense is not available.MRKR TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRKR Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
MRKR Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time |
Marker Therapeutics Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2015 | $10.90 K(-98.1%) | - | - |
| Dec 2014 | $575.50 K(-67.2%) | $0.00(-100.0%) | $543.00 K(-55.7%) |
| Sept 2014 | - | $15.40 K(+77.0%) | $1.23 M(-34.8%) |
| June 2014 | - | $8700.00(-98.3%) | $1.88 M(-13.1%) |
| Mar 2014 | - | $518.90 K(-23.9%) | $2.16 M(+9.3%) |
| Dec 2013 | $1.76 M(+135.7%) | $682.30 K(+1.9%) | $1.98 M(+21.4%) |
| Sept 2013 | - | $669.70 K(+130.0%) | $1.63 M(+38.7%) |
| June 2013 | - | $291.20 K(-13.0%) | $1.17 M(+19.4%) |
| Mar 2013 | - | $334.90 K(+0.5%) | $983.20 K(+32.0%) |
| Dec 2012 | $745.10 K(+9.7%) | $333.30 K(+55.2%) | $745.00 K(+39.9%) |
| Sept 2012 | - | $214.80 K(+114.4%) | $532.50 K(+26.4%) |
| June 2012 | - | $100.20 K(+3.6%) | $421.40 K(+0.5%) |
| Mar 2012 | - | $96.70 K(-20.0%) | $419.30 K(-38.3%) |
| Dec 2011 | $679.30 K | $120.80 K(+16.5%) | $679.30 K(-32.4%) |
| Sept 2011 | - | $103.70 K(+5.7%) | $1.01 M(-26.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2011 | - | $98.10 K(-72.5%) | $1.36 M(-5.0%) |
| Mar 2011 | - | $356.70 K(-20.1%) | $1.43 M(+15.4%) |
| Dec 2010 | $1.24 M(+4.4%) | $446.70 K(-2.6%) | $1.24 M(-11.7%) |
| Sept 2010 | - | $458.60 K(+169.3%) | $1.41 M(+10.9%) |
| June 2010 | - | $170.30 K(+2.8%) | $1.27 M(+9.8%) |
| Mar 2010 | - | $165.60 K(-72.9%) | $1.15 M(-2.9%) |
| Dec 2009 | $1.19 M(+52.8%) | $611.90 K(+91.2%) | $1.19 M(-2.6%) |
| Sept 2009 | - | $320.00 K(+459.4%) | $1.22 M(-19.7%) |
| June 2009 | - | $57.20 K(-71.4%) | $1.52 M(-21.9%) |
| Mar 2009 | - | $199.90 K(-69.0%) | $1.95 M(-0.7%) |
| Dec 2008 | $778.20 K(-43.6%) | $643.90 K(+4.1%) | $1.96 M(+48.9%) |
| Sept 2008 | - | $618.70 K(+27.7%) | $1.32 M(+88.5%) |
| June 2008 | - | $484.40 K(+125.8%) | $698.90 K(+225.8%) |
| Mar 2008 | - | $214.50 K | $214.50 K |
| Dec 2007 | $1.38 M | - | - |
FAQ
- What is the all time high annual interest expense for Marker Therapeutics?
- What is the all time high quarterly interest expense for Marker Therapeutics?
- What is the all time high TTM interest expense for Marker Therapeutics?
What is the all time high annual interest expense for Marker Therapeutics?
Marker Therapeutics all-time high annual interest expense is $1.76 M
What is the all time high quarterly interest expense for Marker Therapeutics?
Marker Therapeutics all-time high quarterly interest expense is $682.30 K
What is the all time high TTM interest expense for Marker Therapeutics?
Marker Therapeutics all-time high TTM interest expense is $2.16 M